Herschel S. Nachlis

Academic Appointments
  • Research Assistant Professor of Government

  • Policy Fellow, Rockefeller Center for Public Policy

Herschel Nachlis is a Research Assistant Professor in the Department of Government and a Policy Fellow in the Nelson A. Rockefeller Center for Public Policy and the Social Sciences at Dartmouth.

+ View more

Contact

603.646.0650
Rockefeller 205 / Spring '22 Office Hours: https://calendly.com/hndartmouth/sp22-office-hours
HB 6108

Department(s)

Government

Center(s)

The Nelson A. Rockefeller Center for Public Policy

Education

  • Ph.D. Princeton University
  • M.A. Princeton University
  • B.A. Macalester College

Selected Publications

Selected Media

"The Biden administration has been sidelining vaccine experts," The Washington Post, 2021

"Why the FDA Hasn't Approved a COVID Shot yet When Millions Are Vaccinated," Newsweek, 2021

"The FDA approved remdesivir to treat Covid-19. Scientists are questioning the evidence." Vox, 2020

"COVID-vaccine results are on the way — and scientists’ concerns are growing," Nature, 2020

"What Is Emergency Use Authorization for COVID-19 Vaccines and Treatments?" AARP, 2020

"Britain’s emergency rush to a vaccine rollout, explained," The Spinoff, 2020

"EUAs are evolving for the better, expert writes," Regulatory Focus, 2020

"FDA Releases New Guidelines for COVID-19 Vaccine Approval: What to Know," Healthline, 2020

"Lessons Learned — or Not — from Hydroxychloroquine Mishap," IRB Advisor, 2020

"A COVID-19 Vaccine at ‘Warp Speed’ Raises Myriad Ethical Questions," IRB Advisor, 2020

"9 Pharma Companies Join to Release Open Letter Promising COVID-19 Vaccine Safety," Healthline, 2020

NHK Japan, 2020

"We Will Not Have a Vaccine by November," Slate, 2020

KHN Morning Briefing, KHN, 2020

"A Win for Science and Transparency: FDA Publishes New, Strict COVID-19 Vaccine Guidelines," Union of Concerned Scientists, 2020

"In case of emergency finish the trial," This Week In Virology, 2020

"Researchers Suggest Improvements to FDA's Authorization, Approval Process Following EUA for Hydroxychloroquine," Pharmacy Times, 2020

"Covid-19 vaccine makers are pushing back against pressures to deliver by Election Day," Vox, 2020

"Viewpoints: The FDA Isn’t Up To The Task Of Reining In The Opioid Epidemic," KHN, 2019